CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1277-1284

  Mateo, V ^a   Lagneaux, L ^b   Bron, D ^b   Biron, G ^d   Armant, M ^c   Delespesse, G ^a   Sarfati, M ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b JULES BORDET INSTITUTE   (Belgium)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE INHIBITOR; CD23 ANTIGEN; CD47 ANTIGEN; CD5 ANTIGEN; DNA FRAGMENT; GAMMA INTERFERON; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL INTERACTION; CELL PROTECTION; CELL SURVIVAL; CELL ULTRASTRUCTURE; CHROMATIN CONDENSATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOCHONDRION SWELLING; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD47; APOPTOSIS; CARRIER PROTEINS; CASPASES; FLOW CYTOMETRY; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MIDDLE AGED;

EID: 0032695010     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15233     Document Type: Article

References (55)

1. Cheson, B.D. et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87, 4990-4997 (1996).
2. Sarfati, M. et al. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 88, 4259-4264 (1996).
3. Dighiero, G. et al. Chlorambucil in indolent chronic lymphocytic leukemia. N. Engl. J. Med. 338, 1506-1514 (1998).
4. Keating, M.J. et al. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 92, 1165-1171 (1998).
5. Dancescu, M. et al. Interleukin-4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J. Exp. Med. 176, 1319-1327 (1992).
6. Fournier, S. et al. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia. Br. J. Haematol. 89, 373-379 (1995).
7. Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C. & Stryckmans, P. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apotosis by contact with normal bone marrow stromal cells. Blood 91, 2387-2396 (1998).
8. Depraetere, V. & Golstein, P. Dismantling in cell death: Molecular mechanisms and relationship to caspase activation. Scand. J. Immunol. 47, 523-531 (1998).
9. Yang, E. & Korsmeyer, S.J. Molecular thanatopsis: A discourse on the Bcl-2 family and cell death. Blood 88, 386-401 (1996).
10. Thornberry, N.A. & Lazebnik. Caspases: Enemies within. Science 281, 1312-1316 (1998).
11. Kawahara, A., Ohsawa, Y., Matsumura, H., Uchiyama, Y. & Nagata, S. Caspase-independent cell killing by fas-associated protein with death domain. J. Cell. Biol. 143, 1353-1360 (1998).
12. De Maria, R. et al. Requirement for GD3 ganglioside in CD95-and ceramide-induced apoptosis. Science 277, 1652-1655 (1997).
13. Lavoie, J.N., Nguyen, M., Marcellus, R.C., Branton, P.E. & Shore, G.C. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J. Cell. Biol. 140, 637-645 (1998).
14. + thymocytes are preferentially induced to die following CD45 cross-linking, through a novel apoptotic pathway. J. Immunol. 159, 4762-4771 (1997).
15. Déas, O. et al. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J. Immunol. 161, 3375-3383 (1998).
16. Quignon, F. et al. PML induces a novel caspase-independent death process. Nature Genet. 20, 259-265 (1998).
17. Monney, L. et al. Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J. Biol. Chem. 273, 6121-6131 (1998).
18. Xiang, J., Chao, D.T. & Korsmeyer, S.J. Bax-induced cell death may not require interleukin-1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93, 14559-14563 (1996).
19. Platt, N., da Silva, R.P. & Gordon, S. Recognizing death: the phagocytosis of apoptotic cells. Trends Cell. Biol. 8, 365-372 (1998).
20. Savill, J. Recognition and phagocytosis of cells undergoing apoptosis. Br. Med. Bull. 53, 491-508 (1997).
21. Savill, J., Hogg, N., Ren, Y. & Hasslet, C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90, 1513-1522 (1992).
22. Lindberg, F.P., Gresham, H.D., Schwarz, E. & Brown, E.J. Molecular cloning of integrin-associated protein: An immunoglobulin family member with multiple membrane-spanning domains implicated in αvβ3-dependent ligand binding. J. Cell Biol. 123, 485-496 (1993).
23. Zhou, M.-J. & Brown, E.J. Leukocyte response integrin and integrin associated protein act as a signal transduction unit in generation of a phagocyte respiratory burst. J. Exp. Med. 178, 1165-1174 (1993).
24. Gao, A. et al. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271, 21-24 (1996).
25. Reinhold, M.I., Lindberg, F.P., Kersh, G.J., Allen, P.M. & Brown, E.J. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent CD28-independent signaling pathway. J. Exp. Med. 185, 1-11 (1997).
26. Fournier, S., Delespesse, G., Rubio, M., Biron, G. & Sarfati, M. CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J. Clin. Invest. 89, 1312-1321 (1992).
27. Shan, D., Ledbetter, J.A. & Press, O.W. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood 91, 1644-1652 (1998).
28. Ghetie, M-A. et al. Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells. Proc. Natl. Acad. Sci. USA 94, 7509-7514 (1997).
29. Truman, J-P. et al. HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes. Blood 89, 1996-2007 (1997).
30. Chaouchi, N., Vazquez, A., Galanaud, P. & Leprince, C. B cell antigen receptor-mediated apoptosis. J. Immunol. 154, 3096-3104 (1995).
31. Kitada, S. et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses. Blood 91, 3379-3389 (1998).
32. McConkey, D.J. et al. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of Bcl-2 and Bax. J. Immunol. 156, 2624-2630 (1996).
33. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. & Reed, J.C. Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82, 1820-1828 (1993).
34. Thomas, A., et al. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship of p53 gene mutation, Bcl-2/Bax proteins in drug resistance. Oncogene 12, 1055-1062 (1996).
35. Panayiotidis, P., Ganeshaguru, K., Jabbar, S. & Hoffbrand, V. Interleukin-4 inhibits apoptotic cell death and loss of the Bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br. J. Haematol. 85, 439-445 (1993).
36. Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L. & Hoffbrand, A.V. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br. J. Haematol. 92, 97-103 (1996).
37. Romano, M.F. et al. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood 92, 990-995 (1998).
38. Wang, D., Freeman, G.J., Levine, H., Ritz, J. & Robertson, M.J. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies. Br. J. Haematol. 97, 409-417 (1997).
39. + tumor cells in B chronic lymphocytic leukemia. Blood 91, 4273-4281 (1998).
40. Douglas, R.S., Capocasale, R.J., Lamb, R.J., Nowell, P.C. & Moore, J.S. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-β. Blood 89, 941-947 (1997).
41. Chandra, J. et al. Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood 90, 3673-3681 (1997).
42. Robertson, L.E. et al. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine. Blood 81, 143-150 (1993).
43. Consoli, U. et al. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia. Blood 91, 1742-1748 (1998).
44. Bellosillo, B. et al. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92, 1406-1414 (1998).
45. Byrd, J.C. et al. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of Bcl-2 modulation or dependence on functional p53. Blood 92, 3804-3816 (1998).
46. Bellosillo, B., Dalmau, M., Colomer, D. & Gil, J. Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood 89, 3378-3384 (1997).
47. Susin, S.A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446 (1999).
48. Zamzami, N., Brenner, C., Marzo, I., Susin, S.A. & Kroemer, G. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16, 2265-2282 (1998).
49. Mower, D.A. Jr. et al. Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J. Immunol. 152, 4832-4842 (1994).
50. Zhuang, J. et al. Dissociation of phagocyte recognition of cells undergoing apoptosis from other features of the apoptotic program. J. Biol. Chem. 273, 15628-15632 (1998).
51. Albert, M.L. et al. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188, 1359-1368 (1998).
52. Savill, J. Phagocytic docking without shocking. Nature 392, 442-443 (1998).
53. Guo, K. et al. Apoptosis-associated gene expression in the corpus luteum of the rat. Biol. Reprod. 58, 739-746 (1998).
54. Cantwell, M.J., Sharma, S., Friedmann, T. & Kipps, T.J. Adenovirus vector infection of chronic lymphocytic leukemia B cells. Blood 88, 4676-4683 (1996).
55. Fuente, Mt., Casanova, B., Garcia, G.M., Silva, A. & Garcia, P.A. Fibronectin interaction with α4β1 integrin prevents apoptosis in B-cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax. Leukemia 13, 266-274 (1999).